Literature DB >> 11464283

Functional identification of LZTS1 as a candidate prostate tumor suppressor gene on human chromosome 8p22.

Y Cabeza-Arvelaiz1, J L Sepulveda, R M Lebovitz, T C Thompson, A C Chinault.   

Abstract

Deletions in the 8p21-22 region of the human genome are among the most common genetic alterations in prostate carcinomas. Several studies in different tumor tissues, including prostate, indicate that there are probably multiple tumor suppressor genes (TSGs) present in this region. To identify candidate TSGs on 8p22 a YAC contig spanning this region was assembled and YAC clones retrofitted with a selectable marker (neo) were transferred into rat prostate AT6.2 cells. Two overlapping YAC clones showed greatly reduced colony-forming efficiency, indicating they may carry a TSG. Two BAC clones encompassing the overlapping region also appeared to exert suppressive effects on the growth of AT6.2 cells. Database searches for genes mapped to the critical region identified a gene known as FEZ1 (LZTS1) as a potential candidate suppressor gene. Subsequent experiments showed that over-expression of LZTS1 cDNA inhibited stable colony-forming efficiencies of AT6.2, HEK-293 and LNCaP cells. In contrast, LZTS1-transfected Rat-1 and RM1 cells were growth-stimulated. Database searches also identified additional isoforms of the LZTS1 mRNA, as well as LZTS1 protein domains reminiscent of those found in transcription factors. Together these data suggest that the LZTS1 gene is involved in the regulation of cell growth and its loss of function may contribute to the development of prostatic carcinomas, as well as other cancers.

Entities:  

Mesh:

Year:  2001        PMID: 11464283     DOI: 10.1038/sj.onc.1204539

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  15 in total

1.  FEZ1/LZTS1 is down-regulated in high-grade bladder cancer, and its restoration suppresses tumorigenicity in transitional cell carcinoma cells.

Authors:  Andrea Vecchione; Hideshi Ishii; Gustavo Baldassarre; Pierfrancesco Bassi; Francesco Trapasso; Hansjuerg Alder; Francesco Pagano; Leonard G Gomella; Carlo M Croce; Raffaele Baffa
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

2.  Down-regulation of tumor suppressor gene FEZ1/LZTS1 in breast carcinoma involves promoter methylation and associates with metastasis.

Authors:  Ling Chen; Zhengmao Zhu; Xiaodong Sun; Xue-Yuan Dong; Jia Wei; Feng Gu; Yu-Lan Sun; Jun Zhou; Jin-Tang Dong; Li Fu
Journal:  Breast Cancer Res Treat       Date:  2008-08-07       Impact factor: 4.872

3.  Pooled analysis of loss of heterozygosity in breast cancer: a genome scan provides comparative evidence for multiple tumor suppressors and identifies novel candidate regions.

Authors:  Brian J Miller; Daolong Wang; Ralf Krahe; Fred A Wright
Journal:  Am J Hum Genet       Date:  2003-09-16       Impact factor: 11.025

4.  Leucine zipper tumor suppressor 2 inhibits cell proliferation and regulates Lef/Tcf-dependent transcription through Akt/GSK3β signaling pathway in lung cancer.

Authors:  Quan-Zhe Cui; Zhong-Ping Tang; Xiu-Peng Zhang; Huan-Yu Zhao; Qian-Ze Dong; Ke Xu; En-Hua Wang
Journal:  J Histochem Cytochem       Date:  2013-06-12       Impact factor: 2.479

5.  Fez1/Lzts1 absence impairs Cdk1/Cdc25C interaction during mitosis and predisposes mice to cancer development.

Authors:  Andrea Vecchione; Gustavo Baldassarre; Hideshi Ishii; Milena S Nicoloso; Barbara Belletti; Fabio Petrocca; Nicola Zanesi; Louise Y Y Fong; Sabrina Battista; Daniela Guarnieri; Raffaele Baffa; Hansjuerg Alder; John L Farber; Peter J Donovan; Carlo M Croce
Journal:  Cancer Cell       Date:  2007-03       Impact factor: 31.743

6.  MicroRNA-135b Regulates Leucine Zipper Tumor Suppressor 1 in Cutaneous Squamous Cell Carcinoma.

Authors:  Edit B Olasz; Lauren N Seline; Ashley M Schock; Nathan E Duncan; Argelia Lopez; Jozef Lazar; Michael J Flister; Yan Lu; Pengyuan Liu; Olayemi Sokumbi; Catherine A Harwood; Charlotte M Proby; Marcy Neuburg; Zelmira Lazarova
Journal:  PLoS One       Date:  2015-05-04       Impact factor: 3.240

7.  LZTS1 downregulation confers paclitaxel resistance and is associated with worse prognosis in breast cancer.

Authors:  Francesca Lovat; Hideshi Ishii; Monica Schiappacassi; Matteo Fassan; Mattia Barbareschi; Enzo Galligioni; Pierluigi Gasparini; Gustavo Baldassarre; Carlo M Croce; Andrea Vecchione
Journal:  Oncotarget       Date:  2014-02-28

8.  Fez1/Lzts1 a new mitotic regulator implicated in cancer development.

Authors:  Andrea Vecchione; Carlo M Croce; Gustavo Baldassarre
Journal:  Cell Div       Date:  2007-08-24       Impact factor: 5.130

9.  Targeting CDC25C, PLK1 and CHEK1 to overcome Docetaxel resistance induced by loss of LZTS1 in prostate cancer.

Authors:  Nader Al Nakouzi; Sophie Cotteret; Frédéric Commo; Catherine Gaudin; Shanna Rajpar; Philippe Dessen; Philippe Vielh; Karim Fizazi; Anne Chauchereau
Journal:  Oncotarget       Date:  2014-02-15

10.  High resolution chromosome 3p, 8p, 9q and 22q allelotyping analysis in the pathogenesis of gallbladder carcinoma.

Authors:  I I Wistuba; A Maitra; R Carrasco; M Tang; P Troncoso; J D Minna; A F Gazdar
Journal:  Br J Cancer       Date:  2002-08-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.